Teva Pharmaceutical Industries Limited (NYSE:TEVA) is in the highlights and many would want to know whether now might be a good time for it to present much upside. Now trading with a market value of 7.89B, the company has a mix of catalysts and obstacles that spring from the nature of its operations. In light of the many issues surrounding this company, we thought it was a good time to take a close look at the numbers in order to form a realistic perspective on the fundamental picture for this stock.
Teva Pharmaceutical Industries Limited (NYSE:TEVA) Fundamentals That Matter […]
Full Post at eglobalist.com